Asembia’s 2024 Summit convened industry leaders, decision-makers, and stakeholders in the biopharmaceutical sector for a comprehensive exploration of the latest trends and pressing issues shaping the landscape of healthcare access, affordability, and innovation. From legislation affecting healthcare to innovative market access strategies, the summit buzzed with discussions on pivotal issues shaping the future of healthcare.

GSW’s market access division Spherico shares their key takeaways from the annual Las Vegas conference.  

Patient Services Programs Assessment: Discussions at the summit delved deep into patient services programs, focusing on how to optimize these programs to better serve patients and address their diverse needs effectively. Key insights stressed the significance of clear and easily understandable content, providing financial assistance information, and fostering community-building initiatives to enhance patient support networks and overall patient satisfaction. After all, these programs are created to not just serve patients, but to help HCPs and their staff ensure patients receive the medications they are prescribed. If patient support programs are not executed correctly, they can cause more stress for HCPs, their staff, and patients.

IRA and Strategic Positioning: Several Asembia sessions focused on the Inflation Reduction Act (IRA) where discussions highlighted its significant healthcare components, including Part D reforms and Medicare negotiation. Biopharma companies were advised to highlight existing clinical data and real-world evidence to underscore their product's value proposition. The emphasis lay on strategically positioning themselves amidst evolving regulatory landscapes, particularly amidst the dynamics of an election year marked by divisions, to navigate forthcoming changes effectively.

Optimizing Market Access for New Biotech and Product Launches: Success in market access necessitates a holistic approach, integrating various stakeholders' needs and identifying pivotal moments in the product journey. Insights stressed the importance of early communication strategies, connecting with stakeholders, and crafting integrated market access plans. Manufacturers were urged to test payer marketing messages effectively, understand payer preferences, and optimize distribution networks for maximum reach and impact. Ultimately, adaptability and stakeholder-centric approaches were highlighted as key strategies for success in navigating the evolving market landscape.

Strategic Collaborations with Health Systems: Our Syneos Health panel highlighted the strategic importance of forging collaborations between biopharma companies and organized customers.. True collaborations are difficult to foster, and take a significant amount of time and trust to be successful. What are the key things that health systems are trying to achieve? What is required in the sales field force to make a collaboration like this work? Ultimately, how can organizations go beyond the contract to create a lasting collaboration that drives value for both parties? Our panelists dove in, emphasizing the need to take the time to understand your customer and their challenges before introducing a partnership like this.

Overall, the Asembia Summit 2024 provided a comprehensive overview of the current challenges and opportunities facing the biopharmaceutical industry, highlighting the importance of collaboration, innovation, and patient-centered approaches in driving meaningful change.

Connect with our market access experts at Spherico:

About the Author:

Hannah Dietz brings over four years of experience in marketing and digital strategy to her role as a Marketing Strategist at Syneos Health Communications. During her time at Syneos Health, she has gained invaluable experience working across agency brands on everything from social media strategy and branding, to public relations and copywriting. Previously, Hannah worked at a digital marketing agency, where she specialized in paid advertising and SEO, and prior to that she worked in public relations.